Current evidence-based guidelines for the diagnosis and treatment of post-traumatic stress disorder (PTSD) are valuable resources and can be used to help develop individual treatment plans for patients. This on-demand… Read More
Individuals living with Alzheimer’s dementia often experience cognitive, behavioral, and functional impairments resulting in the need for professional or non-professional care partner support. Read More
Otsuka Sr. MSL, Dr. Mark Tacelosky spoke with Dr. Brian Iacoviello who guided us through Cognitive Emotional Training for the treatment of major depressive disorder (MDD). Read More
Dr. Chad Worz, Chief Executive Officer of the American Society of Consultant Pharmacists (ASCP) sits down with Justin Rash to discuss the ASCP organization and all that its members bring… Read More
Among respondents currently managing patients with AAD, 91% of respondents believed that there is stigma associated with AAD, 93% endorsed that stigma associated with AAD negatively impacts patient care, and… Read More
Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers… Read More
In this interview, Dennis Sholler sits down with Drs. Marc Agronin and Ara Khachaturian to tackle common questions about agitation associated with Alzheimer’s dementia. Read More
The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More